Protocols
ALLIANCE-ALCHEMIST-A081801 Phase III OPEN TO ACCRUAL
Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST chemo-IO
NRG-GY022 Phase N/A OPEN TO ACCRUAL
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin